Total Payments
$2,924
2024 Payments
$2,836
Companies
21
Transactions
162
Payment Breakdown by Category
Food & Beverage$2,924 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,924 | 162 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $450.58 | 36 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $301.46 | 17 | $0 (2024) |
| Corium, LLC | $298.00 | 10 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $237.22 | 16 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $236.97 | 9 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $203.57 | 15 | $0 (2024) |
| Lundbeck LLC | $189.82 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $110.77 | 6 | $0 (2024) |
| Tris Pharma Inc | $103.30 | 5 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $94.27 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,836 | 158 | ABBVIE INC. ($450.58) |
| 2023 | $88.69 | 4 | Corium, LLC ($24.63) |
All Payment Transactions
162 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: Central Nervous System | ||||||
| 12/17/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $22.00 | General |
| Category: ADHD | ||||||
| 12/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $32.47 | General |
| Category: Neuropsychiatry | ||||||
| 12/12/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: ADHD | ||||||
| 12/12/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $29.45 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: CNS | ||||||
| 11/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $33.41 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.32 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.64 | General |
| Category: Neuropsychiatry | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $33.26 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/29/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Neurology | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $35.85 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 10/24/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Neuroscience | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: CNS | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: NEUROSCIENCE | ||||||
About Michael Malizia, RN
Michael Malizia, RN is a Psychiatric/Mental Health healthcare provider based in Johns Island, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2018. The National Provider Identifier (NPI) number assigned to this provider is 1508357534.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Malizia, RN has received a total of $2,924 in payments from pharmaceutical and medical device companies, with $2,836 received in 2024. These payments were reported across 162 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,924).
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Johns Island, SC
- Active Since 05/25/2018
- Last Updated 10/28/2023
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508357534
Products in Payments
- VRAYLAR (Drug) $450.58
- REXULTI (Drug) $398.50
- Azstarys (Drug) $298.00
- CAPLYTA (Drug) $237.22
- INGREZZA (Drug) $236.97
- HETLIOZ (Drug) $203.57
- SPRAVATO (Drug) $110.77
- Dyanavel XR (Drug) $103.30
- TRINTELLIX (Drug) $94.27
- Adzenys XR-ODT (Drug) $93.38
- LYBALVI (Drug) $90.85
- Xelstrym (Drug) $88.36
- ZURZUVAE (Drug) $68.19
- COBENFY (Drug) $62.71
- LOREEV XR (Drug) $48.64
- Austedo XR (Drug) $48.46
- JORNAY PM (Drug) $45.51
- ABILIFY ASIMTUFII (Drug) $41.85
- UZEDY (Drug) $33.85
- Auvelity (Drug) $32.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.